Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Nov;28(11):2580–2584. doi: 10.1128/jcm.28.11.2580-2584.1990

Characterization of Shigella dysenteriae serotypes 11, 12, and 13.

H G Wathen-Grady 1, L E Britt 1, N A Strockbine 1, I K Wachsmuth 1
PMCID: PMC268232  PMID: 1701447

Abstract

We conducted serologic and biochemical studies on strains of three provisional Shigella serotypes. Included were 19 strains of serotype 3873-50 from three countries (1 from Mexico, 1 from Netherlands Antilles, and 17 from the United States), 13 strains of serotype 3341-55 from three countries (1 from Canada, 1 from Bulgaria, and 11 from the United States), and 19 strains of serotype 19809-73 from two countries (16 from Israel and 3 from the United States). Reactions of these strains with homologous and heterologous Shigella antisera showed that serotypes 3873-50 and 19809-73 were unique. Strains of serotype 3341-55 shared an identical antigen with Shigella boydii 18; however, they were distinguished from S. boydii 18 biochemically and with absorbed sera. Strains of the three serotypes were biochemically most similar to Shigella dysenteriae. Like other shigellae, strains from each serotype were invasive in the Serény assay. Although biochemically similar to S. dysenteriae, none of the provisional serotypes produced Shiga toxin or the biologically related toxin, Shiga-like toxin II, produced by some strains of Escherichia coli. On the basis of these results and other published findings, we support earlier proposals to add the three provisional serotypes 3873-50, 3341-55, and 19809-73 to the Shigella schema and will include them as S. dysenteriae 11, 12, and 13, respectively.

Full text

PDF
2580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. EWING W. H., HUCKS M. C. Four new provisional serotypes of Shigella. J Immunol. 1952 Nov;69(5):575–580. [PubMed] [Google Scholar]
  4. EWING W. H., REAVIS R. W., DAVIS B. R. Provisional Shigella serotypes. Can J Microbiol. 1958 Apr;4(2):89–107. doi: 10.1139/m58-012. [DOI] [PubMed] [Google Scholar]
  5. Gentry M. K., Dalrymple J. M. Quantitative microtiter cytotoxicity assay for Shigella toxin. J Clin Microbiol. 1980 Sep;12(3):361–366. doi: 10.1128/jcm.12.3.361-366.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gross R. J., Thomas L. V., Cheasty T., Rowe B., Lindberg A. A. Four new provisional serovars of Shigella. J Clin Microbiol. 1989 May;27(5):829–831. doi: 10.1128/jcm.27.5.829-831.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gross R. J., Thomas L. V., Rowe B. New provisional serovar (E10163) of Shigella boydii. J Clin Microbiol. 1980 Aug;12(2):167–169. doi: 10.1128/jcm.12.2.167-169.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hickman F. W., Farmer J. J., 3rd Salmonella typhi: identification, antibiograms, serology, and bacteriophage typing. Am J Med Technol. 1978 Dec;44(12):1149–1159. [PubMed] [Google Scholar]
  9. Konowalchuk J., Speirs J. I., Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun. 1977 Dec;18(3):775–779. doi: 10.1128/iai.18.3.775-779.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SERENY B. Experimental keratoconjunctivitis shigellosa. Acta Microbiol Acad Sci Hung. 1957;4(4):367–376. [PubMed] [Google Scholar]
  11. Sansonetti P. J., Kopecko D. J., Formal S. B. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982 Mar;35(3):852–860. doi: 10.1128/iai.35.3.852-860.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sansonetti P. J., Kopecko D. J., Formal S. B. Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. Infect Immun. 1981 Oct;34(1):75–83. doi: 10.1128/iai.34.1.75-83.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shmilovitz M., Kretzer B., Levi S. A new provisional serovar of Shigella dysenteriae. J Clin Microbiol. 1985 Feb;21(2):240–242. doi: 10.1128/jcm.21.2.240-242.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Strockbine N. A., Marques L. R., Newland J. W., Smith H. W., Holmes R. K., O'Brien A. D. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun. 1986 Jul;53(1):135–140. doi: 10.1128/iai.53.1.135-140.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wathen-Grady H. G., Davis B. R., Morris G. K. Addition of three new serotypes of Shigella boydii to the Shigella schema. J Clin Microbiol. 1985 Jan;21(1):129–132. doi: 10.1128/jcm.21.1.129-132.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES